The Global Health Innovative Technology (GHIT) Fund announced a total of approximately 750 million yen (US$6.6 million*) to invest in six partnerships to develop new lifesaving drugs for malaria and Chagas Disease, a vaccine for malaria, and diagnostics for tuberculosis […]
Recent Posts
- BIOTEC (NSTDA) x IMCAS (China) Strengthen Mekong Food Security through Edible Mushroom Training in Beijing
12/16/2025 - BIOTEC’s researchers have received funding from BactiVac, the Bacterial Vaccines Network to develop a Novel Vaccine Approach to Reduce Antibiotic Dependence in Aquaculture
12/11/2025 - BIOTEC Collaborates with FAO and UN Agencies at BIIF 2025 and Hosts Delegations to Explore Future Collaboration
12/04/2025